vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Knowles Corp (KN). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $153.1M, roughly 1.8× Knowles Corp). Knowles Corp runs the higher net margin — 6.3% vs 0.7%, a 5.6% gap on every dollar of revenue. On growth, Knowles Corp posted the faster year-over-year revenue change (22.7% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-3.1M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Knowles Corporation is a global leading designer and manufacturer of advanced micro-acoustic, audio processing, and precision component solutions. It serves core segments including consumer electronics, automotive, medical technology, and industrial markets, offering products such as MEMS microphones, hearing aid components, and edge audio processing ICs to worldwide clients.

HCM vs KN — Head-to-Head

Bigger by revenue
HCM
HCM
1.8× larger
HCM
$270.8M
$153.1M
KN
Growing faster (revenue YoY)
KN
KN
+39.2% gap
KN
22.7%
-16.5%
HCM
Higher net margin
KN
KN
5.6% more per $
KN
6.3%
0.7%
HCM
More free cash flow
HCM
HCM
$6.5M more FCF
HCM
$3.4M
$-3.1M
KN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
KN
KN
Revenue
$270.8M
$153.1M
Net Profit
$2.0M
$9.7M
Gross Margin
37.7%
43.8%
Operating Margin
-13.2%
10.4%
Net Margin
0.7%
6.3%
Revenue YoY
-16.5%
22.7%
Net Profit YoY
-83.6%
585.0%
EPS (diluted)
$0.00
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
KN
KN
Q1 26
$153.1M
Q4 25
$270.8M
$162.2M
Q3 25
$152.9M
Q2 25
$277.7M
$145.9M
Q1 25
$324.5M
$132.2M
Q4 24
$142.5M
Q3 24
$142.5M
Q2 24
$305.7M
$204.7M
Net Profit
HCM
HCM
KN
KN
Q1 26
$9.7M
Q4 25
$2.0M
$21.0M
Q3 25
$17.4M
Q2 25
$455.0M
$7.8M
Q1 25
$11.9M
$-2.0M
Q4 24
$18.5M
Q3 24
$500.0K
Q2 24
$25.8M
$-259.3M
Gross Margin
HCM
HCM
KN
KN
Q1 26
43.8%
Q4 25
37.7%
44.7%
Q3 25
45.7%
Q2 25
0.1%
41.5%
Q1 25
48.0%
40.3%
Q4 24
42.7%
Q3 24
44.1%
Q2 24
41.1%
28.2%
Operating Margin
HCM
HCM
KN
KN
Q1 26
10.4%
Q4 25
-13.2%
15.9%
Q3 25
16.9%
Q2 25
-1.3%
10.1%
Q1 25
-5.0%
3.0%
Q4 24
10.8%
Q3 24
13.1%
Q2 24
-9.0%
6.2%
Net Margin
HCM
HCM
KN
KN
Q1 26
6.3%
Q4 25
0.7%
12.9%
Q3 25
11.4%
Q2 25
163.8%
5.3%
Q1 25
3.7%
-1.5%
Q4 24
13.0%
Q3 24
0.4%
Q2 24
8.4%
-126.7%
EPS (diluted)
HCM
HCM
KN
KN
Q1 26
$0.13
Q4 25
$0.00
$0.23
Q3 25
$0.20
Q2 25
$0.52
$0.09
Q1 25
$0.01
$-0.02
Q4 24
$0.20
Q3 24
$0.01
Q2 24
$0.03
$-2.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
KN
KN
Cash + ST InvestmentsLiquidity on hand
$1.4B
$41.0M
Total DebtLower is stronger
$93.2M
$131.0M
Stockholders' EquityBook value
$1.2B
$780.2M
Total Assets
$1.8B
$1.1B
Debt / EquityLower = less leverage
0.08×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
KN
KN
Q1 26
$41.0M
Q4 25
$1.4B
$54.2M
Q3 25
$92.5M
Q2 25
$1.4B
$103.2M
Q1 25
$836.1M
$101.9M
Q4 24
$130.1M
Q3 24
$92.6M
Q2 24
$802.5M
$84.0M
Total Debt
HCM
HCM
KN
KN
Q1 26
$131.0M
Q4 25
$93.2M
$114.0M
Q3 25
$176.3M
Q2 25
$93.4M
$190.0M
Q1 25
$82.8M
$188.8M
Q4 24
$202.5M
Q3 24
$225.0M
Q2 24
$82.1M
$261.2M
Stockholders' Equity
HCM
HCM
KN
KN
Q1 26
$780.2M
Q4 25
$1.2B
$775.8M
Q3 25
$751.8M
Q2 25
$1.2B
$746.1M
Q1 25
$759.9M
$755.8M
Q4 24
$756.0M
Q3 24
$777.4M
Q2 24
$740.1M
$753.0M
Total Assets
HCM
HCM
KN
KN
Q1 26
$1.1B
Q4 25
$1.8B
$1.1B
Q3 25
$1.1B
Q2 25
$1.8B
$1.1B
Q1 25
$1.3B
$1.1B
Q4 24
$1.1B
Q3 24
$1.2B
Q2 24
$1.3B
$1.2B
Debt / Equity
HCM
HCM
KN
KN
Q1 26
0.17×
Q4 25
0.08×
0.15×
Q3 25
0.23×
Q2 25
0.08×
0.25×
Q1 25
0.11×
0.25×
Q4 24
0.27×
Q3 24
0.29×
Q2 24
0.11×
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
KN
KN
Operating Cash FlowLast quarter
$8.2M
$0
Free Cash FlowOCF − Capex
$3.4M
$-3.1M
FCF MarginFCF / Revenue
1.2%
-2.0%
Capex IntensityCapex / Revenue
1.8%
7.1%
Cash ConversionOCF / Net Profit
4.21×
0.00×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
KN
KN
Q1 26
$0
Q4 25
$8.2M
Q3 25
$29.1M
Q2 25
$-72.9M
$36.4M
Q1 25
$40.3M
$1.3M
Q4 24
Q3 24
$52.8M
Q2 24
$-39.8M
$24.9M
Free Cash Flow
HCM
HCM
KN
KN
Q1 26
$-3.1M
Q4 25
$3.4M
Q3 25
$21.4M
Q2 25
$-82.2M
$31.3M
Q1 25
$32.5M
$-2.7M
Q4 24
Q3 24
$49.1M
Q2 24
$-49.9M
$21.7M
FCF Margin
HCM
HCM
KN
KN
Q1 26
-2.0%
Q4 25
1.2%
Q3 25
14.0%
Q2 25
-29.6%
21.5%
Q1 25
10.0%
-2.0%
Q4 24
Q3 24
34.5%
Q2 24
-16.3%
10.6%
Capex Intensity
HCM
HCM
KN
KN
Q1 26
7.1%
Q4 25
1.8%
9.4%
Q3 25
5.0%
Q2 25
3.3%
3.5%
Q1 25
2.4%
3.0%
Q4 24
2.3%
Q3 24
2.6%
Q2 24
3.3%
1.6%
Cash Conversion
HCM
HCM
KN
KN
Q1 26
0.00×
Q4 25
4.21×
Q3 25
1.67×
Q2 25
-0.16×
4.67×
Q1 25
3.38×
Q4 24
Q3 24
105.60×
Q2 24
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons